MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 5841-5850 Newer>
The Motley Fool
August 25, 2009
Jennifer Schonberger
7 Health-Care Stocks to Nurse Your Portfolio As fears about the health-care bill abate, valuations in the sector look ripe. mark for My Articles 289 similar articles
Wired
August 24, 2009
Steve Silberman
Placebos Are Getting More Effective. Drugmakers Are Desperate to Know Why. The fact that taking a faux drug can powerfully improve some people's health -- the so-called placebo effect -- has long been considered an embarrassment to the serious practice of pharmacology. mark for My Articles 632 similar articles
Chemistry World
August 24, 2009
Sarah Houlton
Indian court dismisses Bayer's patent law case Bayer has failed in its attempt to stop Indian regulators giving marketing authorization to a generic version of its kidney cancer drug Nexavar (sorafenib), despite its 20 year patent having only been granted last year. mark for My Articles 383 similar articles
The Motley Fool
August 24, 2009
Brian Orelli
J&J Would Rather Not Say Drug delayed, reason unknown. Should shareholders be worried? It's hard to tell. mark for My Articles 1092 similar articles
CRM
August 1, 2009
Lauren McKay
The New Prescription for Pharma To address trends in the industry, pharmaceutical companies must do more with less and reshape their messages - not the easiest of tasks. mark for My Articles 221 similar articles
CRM
August 1, 2009
Lauren McKay
Patience for Patients Improved surveying techniques improve a hospital's patient-centricity. mark for My Articles 72 similar articles
The Motley Fool
August 21, 2009
Brian Orelli
Forget Swine Flu: The Big Money Is Here Vaccines are pharma's, and possibly investors', best friend. mark for My Articles 401 similar articles
The Motley Fool
August 21, 2009
Brian Orelli
ZymoGenetics Goes in for the Kill ZymoGenetics went on the offensive, asking the Food and Drug Administration to pull competitor King Pharmaceuticals' Thrombin-JMI off the market. mark for My Articles 24 similar articles
AskMen.com Drug CEOs: Not That Rich? Billionaire Mayor Michael Bloomberg defended multibillion-dollar pharmaceutical companies and their chief executives on Friday, declaring that they "don't make a lot of money" and shouldn't be scapegoats in the health care debate. mark for My Articles 31 similar articles
Popular Mechanics
August 20, 2009
Emily Anthes
7 Next-Gen Bandages That Help Heal Wounds What is in store for the problem of wound care supported by the latest biology and chemistry insights mark for My Articles 30 similar articles
<Older 5841-5850 Newer>    Return to current articles.